You are here

US FDA approves generic cholesterol-lowering pill

Nod for generic Crestor deals blow to AstraZeneca as price could drop 80-90%

New York

THE US Food and Drug Administration (FDA) said on Wednesday that it had approved generic versions of the blockbuster cholesterol-lowering pill Crestor, rejecting a last-ditch and controversial effort by AstraZeneca to stop cheaper competition from reaching pharmacy shelves.

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom